Books.org participates in affiliate programs including Bookshop.org and the Amazon Services LLC Associates Program. We may earn a commission from qualifying purchases made through links on this page, at no additional cost to you.
Overview
Senior physicians, cardiologists, urologists, psychologists, and pharmacologists critically review the relation between heart disease and erectile dysfunction (ED) and explain for the practicing physician the effective new treatment options available for the cardiac patient with ED. The authors detail in concise language the latest thinking about the risk of sexually induced cardiac events, the efficacy and risks to cardiac patients of drugs used to treat sexual dysfunction, and the expert guidelines developed by prominent organizations on the optimal approach to sexual dysfunction in the cardiac patient. They also discuss the physiology of ED and the currently available therapies (sildenafil, tadalafil, and vardenafil) may interact with the cardiac system, and the potential application of newer agents like phosphodiesterase-5 inhibitors to cardiovascular disease.
Synopsis
It is now generally appreciated that erectile dysfunction (ED) is often an early warning sign of vascular disease. Kloner (Good Samaritan Hospital, University of Southern California) collects material by physicians, cardiologists, urologists, psychologists, and pharmacologists, examining the relationship between heart disease and ED and explaining new treatment options for cardiac patients with ED. Contributors review the latest thinking on the risk of sexually induced cardiac events and the risks of drugs used to treat sexual dysfunction, and discuss the physiology of ED and the potential application of newer phosphodiesterase-5 inhibitors to cardiovascular disease. Readership includes cardiologists, urologists, primary care physicians, and sex therapists. Annotation ©2004 Book News, Inc., Portland, OR
Doody Review Services
Reviewer:Allen D. Seftel, MD(Case Western Reserve University)
Description:This well rounded book looks at a new and exciting area of sexual medicine as it relates to the heart and to heart disease. The 18 chapters cover a breadth of sexual medicine and heart disease issues.
Purpose:This book is intended to review the topic of erectile dysfunction from a cardiac standpoint. This is a very important area that is both timely and under-served. The book has exceeded the authors' objectives.
Audience:Although not explicitly stated, this book appears to be written for the practicing clinician. Urologists, cardiologists, and primary care specialists are the main audience for this book. The authors are all highly qualified, well respected authorities in their specific areas.
Features:The topics covered in this book are germane to sexual medicine and cardiovascular disease. There are specific chapters on sildenanfil and its mechanism of action, the importance of phosphodiesterase inhibition to the cardiovascular tree, sexual activity and cardiovascular disease, as well as cardiovascular effects of the phosphodiesterase inhibitors. The book is heavy on text. Additional tables, graphs and figures would be welcome.
Assessment:This is the first book of its kind. Dr Kloner and colleagues deserve credit for bringing this important topic to the forefront.
Editorials
From The Critics
Reviewer: Allen D. Seftel, MD(Case Western Reserve University)Description: This well rounded book looks at a new and exciting area of sexual medicine as it relates to the heart and to heart disease. The 18 chapters cover a breadth of sexual medicine and heart disease issues.
Purpose: This book is intended to review the topic of erectile dysfunction from a cardiac standpoint. This is a very important area that is both timely and under-served. The book has exceeded the authors' objectives.
Audience: Although not explicitly stated, this book appears to be written for the practicing clinician. Urologists, cardiologists, and primary care specialists are the main audience for this book. The authors are all highly qualified, well respected authorities in their specific areas.
Features: The topics covered in this book are germane to sexual medicine and cardiovascular disease. There are specific chapters on sildenanfil and its mechanism of action, the importance of phosphodiesterase inhibition to the cardiovascular tree, sexual activity and cardiovascular disease, as well as cardiovascular effects of the phosphodiesterase inhibitors. The book is heavy on text. Additional tables, graphs and figures would be welcome.
Assessment: This is the first book of its kind. Dr Kloner and colleagues deserve credit for bringing this important topic to the forefront.
4 Stars! from Doody